Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: A specific marker for severity

International Journal of Dermatology

Volumn 48, Issue 8, 2009, Pages 822-829

  Ezzat, Mohamed Hesham Mohamed ^a,b   Sallam, Mohamed Abdelnaeem ^a   Shaheen, Kareem Yehia Ali ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; MUCOSA ASSOCIATED EPITHELIAL CHEMOKINE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; ATOPIC DERMATITIS; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REMISSION; SCORING SYSTEM;

ASTHMA; BIOLOGICAL MARKERS; CELL MOVEMENT; CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EPITHELIUM; FEMALE; HUMANS; INFANT; MALE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, HELPER-INDUCER; UP-REGULATION;

EID: 68049103341     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04069.x     Document Type: Article

References (32)

1. Olesen AB, Andersen G, Jeppesen DL, et al. Thymus is enlarged in children with current atopic dermatitis. A cross-sectional study. Acta Derm Venereol 2005; 85: 240-243.
2. Vestergaard C, Johansen C, Otkjaer K, et al. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. Cytokine 2005; 29: 49-55.
3. Hieshima K, Ohtani H, Shibano M, et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 2003; 170: 1452-1461.
4. Wang W, Soto H, Oldham ER, et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000; 275: 22, 313-22, 323.
5. Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig) A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med 2004; 200: 805-809.
6. Hieshima K, Kawasaki Y, Hanamoto H, et al. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J Immunol 2004; 173: 3668-3675.
7. Leung DY. Atopic dermatitis. In: Behrman RE, Kleigman RM, Jenson HB, eds. Nelson Textbook of Pediatrics, 17th edn. Philadelphia, PA: W.B. Saunders, 2004: 774-778.
8. Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338: 137-140.
9. Kunz B, Oranje AP, Labreze L, et al. Clinical validation and guidelines for the SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195: 10-19.
10. Pucci N, Novembre E, Cammarata MG, et al. Scoring atopic dermatitis in infants and young children: Distinctive features of the SCORAD index. Allergy 2005; 60: 113-116.
11. Sprikkelman AB, Tupker RA, Burgerhof H, et al. Severity scoring of atopic dermatitis: A comparison of three scoring systems. Allergy 1997; 52: 944-949.
12. Liu AH, Spahn JD, Leung DY. Childhood asthma. In: Behrman RE, Kleigman RM, Jenson HB, eds. Nelson Textbook of Pediatrics, 17th edn. Philadelphia, PA: W.B. Saunders, 2004: 760-773.
13. National Heart, Lung, and Blood Institute (NHLBI). National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051A. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, 1997.
14. Geaghan SM. Normal blood values: Selected reference values for neonatal, pediatric and adult populations. In: Hoffman R, Benz EJ, Shattil SJ, et al. eds. Hematology Basic Principles and Practice, 3rd edn. New York: Churchill Livingstone, 2000: 2520-2528.
15. Kagami S, Kakinuma T, Saeki H, et al. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 2005; 124: 1088-1090.
16. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-165.
17. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999; 96: 14, 470-14, 475.
18. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002; 38: 881-885.
19. Hijnen D, De Bruin-Weller M, Oosting B, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004; 113: 334-340.
20. Kakinuma T, Saeki H, Tsunemi Y, et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003; 111: 592-597.
21. 4+ CD8+ (thymocyte-like) T lymphocytes present in blood and skin from patients with atopic dermatitis suggest immune dysregulation. Br J Dermatol 2001; 144: 1140-1147.
22. Giustizieri ML, Mascia F, Frezzolini A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis vulgaris show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001; 107: 871-877.
23. Reiss Y, Proudfoot AE, Power CA, et al. CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001; 194: 1541-1547.
24. John AE, Thomas MS, Berlin AA, et al. Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation. Am J Pathol 2005; 166: 345-353.
25. 3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci USA 2002; 99: 1479-1484.
26. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: What exactly are we measuring? J Invest Dermatol 2003; 120: 932-941.
27. Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 2004; 15: 86-88.
28. RokaiéR, Labanauskas L, Vaideliené L. Role of the skin patch test in diagnosing food allergy in children with atopic dermatitis. Medicina (Kaunas) 2004; 40: 1081-1087.
29. Seidenari S, Guisti F, Bertoni L, et al. Combined skin prick and patch testing enhances identification of peanut allergic patients with atopic dermatitis. Allergy 2003; 58: 495.
30. 3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 2002; 109: 621-628.
31. Mukai H, Noguchi T, Kamimura K, et al. Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. J Dermatol 1990; 17: 477-481.
32. Jacyk WK, Ungerer JP. Serum lactate dehydrogenase activity in exfoliative dermatitis. J Dermatol 1991; 18: 743.